Page last updated: 2024-08-23

substance p and Parkinsonian Disorders

substance p has been researched along with Parkinsonian Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, OY; de Souza Silva, MA; Nikolaus, S; Wang, AL1
Ali, S; Chen, SH; Chu, CH; Hong, JS; Jiang, L; Kim, HC; Oyarzabal, E; Qian, L; Robinson, B; Wang, Q; Wilson, B1
Jia, J; Li, B; Liu, L; Pan, Y; Sun, Z; Wang, H; Wang, X; Yu, F; Zhang, L1
Betarbet, R; Greenamyre, JT1
de Yébenes, JG; Fernández-Ruiz, J; González, S; Lastres-Becker, I; Mena, MA; Ramos, JA; Serrano, A1
Fernandez-Barreiro, A; Fernandez-Villalba, E; Gomez-Gallego, M; Herrero, MT1
Chen, L; Cui, QL; Yung, WH1
Cheetham, S; Jenner, P; Lane, EL1

Other Studies

8 other study(ies) available for substance p and Parkinsonian Disorders

ArticleYear
NK₃ receptor agonism reinstates temporal order memory in the hemiparkinsonian rat.
    Behavioural brain research, 2015, May-15, Volume: 285

    Topics: Animals; Male; Medial Forebrain Bundle; Memory; Movement; Neuropsychological Tests; Nootropic Agents; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Random Allocation; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Time Perception

2015
Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Sep-10, Volume: 34, Issue:37

    Topics: Animals; Dopamine; Dopaminergic Neurons; Enzyme Activation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; NADPH Oxidases; Parkinsonian Disorders; Receptors, Neurokinin-1; Substance P

2014
Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats.
    Behavioural brain research, 2009, Dec-14, Volume: 205, Issue:1

    Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Disease Models, Animal; Dopamine; Dyskinesias; Electroacupuncture; Enkephalins; Glutamate Decarboxylase; Male; Medial Forebrain Bundle; Motor Activity; Neurons; Parkinsonian Disorders; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Substance P; Tyrosine 3-Monooxygenase

2009
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Experimental neurology, 2004, Volume: 189, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Disease Models, Animal; Dopamine; Down-Regulation; Enkephalins; Female; Functional Laterality; Globus Pallidus; Macaca mulatta; Neostriatum; Neuropeptides; Parkinsonian Disorders; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance P; Substantia Nigra; Up-Regulation

2004
Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice.
    Brain research, 2005, Jun-07, Volume: 1046, Issue:1-2

    Topics: Analysis of Variance; Animals; Basal Ganglia; Disease Models, Animal; Enkephalins; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Parkinsonian Disorders; Protein Precursors; Receptor, Cannabinoid, CB1; RNA, Messenger; Sex Factors; Statistics, Nonparametric; Substance P; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases

2005
Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Animals; Biomarkers; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Down-Regulation; Electron Transport Complex IV; Female; In Situ Hybridization; Macaca fascicularis; Neurons; Neurotoxins; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Protein Subunits; RNA, Messenger; Substance P

2007
Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats.
    Neuroscience research, 2008, Volume: 60, Issue:2

    Topics: Action Potentials; Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Compulsive Behavior; Disease Models, Animal; Drug Interactions; Globus Pallidus; Male; Medial Forebrain Bundle; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substance P; Tropanes

2008
Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:3

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Chlorobenzenes; Corpus Striatum; Cyclobutanes; Dynorphins; Enkephalins; Gene Expression; In Situ Hybridization; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; RNA, Messenger; Substance P; Time

2008